Actionable news
0
All posts from Actionable news
Actionable news in NBIX: Neurocrine Biosciences, Inc.,

Neurocrine Biosciences's President and CEO was just granted 167,850 options and restricted shares

Kevin Charles Gorman, Neurocrine Biosciences's President and CEO and a director of the company, just received 167,850 options and restricted shares from the company. The strike prices of the options received ranged from $0.00 to $35.99, and these expire on February 05, 2026. The restricted shares don't become available to Gorman until February 05, 2020. Gorman now has at least 109,100 options, and at least 58,750 restricted shares.

Some additional info was provided as follows:

Each Restricted Stock Unit represents a contingent right to receive one share of the Neurocrine Common Stock...

More